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ABSTRACT 
 
Question: From previous work, this group had discovered that infection of dendritic cells 
(DC) caused by the intracellular parasite (Toxoplasma gondii) induced a hyper-migratory 
state in DC which was a possible mechanism of the protozoan dissemination. For this study, 
their question was whether ϒ-aminobutyric acid (GABA) signaling was the possible 
mechanism underlying the control to the migratory properties of the infected DC. 
Methods: To affirm the hypothesis, a series of complimentary experiments were conducted 
using both animal and human DC, also in vitro and in vivo. 
Main results: The main results of the experiments were as follows: 
First, murine and human DC produced GABA upon T. gondii infection. By quantitatively 
measuring GABA in the supernatant by enzyme-linked immunosorbent assay (ELISA), they 
found that live Toxoplasma infection of mouse DC, from the three predominant genotypes, 
increased GABA and the secretion occurred rapidly following infection. In addition, the 
fluorescence-activated cell sorting (FACS) of infected DC populations demonstrated that 
GABA production happened mainly in green fluorescent protein (GFP) + DC. 
Second, functional GABAA receptors were expressed in mouse and human DC. The 
GABAA receptors of a3, ß3, and r1 subunit expression was determined with quantitative 
reverse transcription polymerase reaction (RT-qPCR). Subsequent immune-cytochemical 
stainings indicated expression of the ß3 subunit in both infected and non infected DC. These 
receptors were proved to be functional in the electrophysiology tests as membrane currents 
were induced in T. gondii-infected DC. 
Third, transmigration of infected DC in vitro was reduced by targeting GABA synthesis and 
transport. Addition of inhibitors of GABA system such as glutamic acid decarboxylase 
(GAD) inhibitor (SC) and gamma-aminobutyric acid transporter 4 (GAT4) inhibitor (SNAP) 
to the infected DC had significantly decreased the secretion of GABA and also the 
transmigration of infected DC. 
Fourth, the motility and chemotaxis of infected DC in vitro was modulated by GABAergic 
signaling in vitro. In a chemotaxis chamber system which consisted of chemokine CCL19 
concentration gradient, Toxoplasma-infected DC demonstrated an increased random 
directional motility and velocity even in absence of chemokine compared to non-infected DC. 
Finally, up-regulation of CCR7 in human and mouse DC were observed upon T. gondii 
infection in vitro. Furthermore, the dissemination of T. gondii in vivo was reduced by 
GABAergic inhibition in adoptively transferred infected DC as shown in the bioluminescence 
imaging (BLI) studies. Photonic emissions were also observed ex vivo in different organs, 
and the authors noted significant differences in the emissions on days 1–2 in the brain 
parenchyma. 
Conclusion: The authors concluded that GABAergic signaling modulated the transmigration 
of DC and that the intracellular pathogen Toxoplasma gondii seizes the GABAergic signaling 
of DC like a trojan horse mechanism to assure dissemination. 
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